The targets and indicators of Russia’s state public health program up to 2020

Studying the targets and indicators of the Public Health Development Program up to 2020 concerning antituberculosis (anti-TB) care to the population may lead to the conclusion that they may be fulfilled in the Russian Federation as a whole. The difficulties in fulfilling the indicators are associate...

Full description

Bibliographic Details
Main Authors: O. B. Nechaeva, S. A. Sterlikov, N. B. Khurieva
Format: Article
Language:Russian
Published: NEW TERRA Publishing House 2014-12-01
Series:Tuberkulez i Bolezni Lëgkih
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/312
id doaj-c18b9de3a8fe45e59077dc8694d1d29f
record_format Article
spelling doaj-c18b9de3a8fe45e59077dc8694d1d29f2021-07-28T20:57:40ZrusNEW TERRA Publishing HouseTuberkulez i Bolezni Lëgkih2075-12302542-15062014-12-010122534312The targets and indicators of Russia’s state public health program up to 2020O. B. Nechaeva0S. A. Sterlikov1N. B. Khurieva2ФГБУ «Центральный НИИ организации и информатизации здравоохранения» Минздрава России, г. МоскваФГБУ «Центральный НИИ организации и информатизации здравоохранения» Минздрава России, г. МоскваФГБУ «Центральный НИИ организации и информатизации здравоохранения» Минздрава России, г. МоскваStudying the targets and indicators of the Public Health Development Program up to 2020 concerning antituberculosis (anti-TB) care to the population may lead to the conclusion that they may be fulfilled in the Russian Federation as a whole. The difficulties in fulfilling the indicators are associated with the low level of tuberculosis detection in a number of subjects of the Russian Federation; the continuing development of the HIV epidemic; the inadequate development of bacteriological diagnosis of the drug sensitivity of the tuberculosis pathogen to anti-TB drugs; the nonuniform funding of anti-TB measures in the subjects of the Russian Federation – the annual financing per tuberculosis patient differs by 40 times, including that of the purchase of anti-TB drugs by 63 times. Having no federal financial assistance in purchasing reserve anti-TB drugs and consumables for microbiological tests, it is impossible to diagnose multidrug resistance and to cure patients with multidrug-resistant tuberculosis at the expense of the budgets of the Russian Federation’s subjects.https://www.tibl-journal.com/jour/article/view/312tuberculosistuberculosis institutionspublic health financingmultidrug resistancehiv infectionrussia’s state public health development programtargetsindicators
collection DOAJ
language Russian
format Article
sources DOAJ
author O. B. Nechaeva
S. A. Sterlikov
N. B. Khurieva
spellingShingle O. B. Nechaeva
S. A. Sterlikov
N. B. Khurieva
The targets and indicators of Russia’s state public health program up to 2020
Tuberkulez i Bolezni Lëgkih
tuberculosis
tuberculosis institutions
public health financing
multidrug resistance
hiv infection
russia’s state public health development program
targets
indicators
author_facet O. B. Nechaeva
S. A. Sterlikov
N. B. Khurieva
author_sort O. B. Nechaeva
title The targets and indicators of Russia’s state public health program up to 2020
title_short The targets and indicators of Russia’s state public health program up to 2020
title_full The targets and indicators of Russia’s state public health program up to 2020
title_fullStr The targets and indicators of Russia’s state public health program up to 2020
title_full_unstemmed The targets and indicators of Russia’s state public health program up to 2020
title_sort targets and indicators of russia’s state public health program up to 2020
publisher NEW TERRA Publishing House
series Tuberkulez i Bolezni Lëgkih
issn 2075-1230
2542-1506
publishDate 2014-12-01
description Studying the targets and indicators of the Public Health Development Program up to 2020 concerning antituberculosis (anti-TB) care to the population may lead to the conclusion that they may be fulfilled in the Russian Federation as a whole. The difficulties in fulfilling the indicators are associated with the low level of tuberculosis detection in a number of subjects of the Russian Federation; the continuing development of the HIV epidemic; the inadequate development of bacteriological diagnosis of the drug sensitivity of the tuberculosis pathogen to anti-TB drugs; the nonuniform funding of anti-TB measures in the subjects of the Russian Federation – the annual financing per tuberculosis patient differs by 40 times, including that of the purchase of anti-TB drugs by 63 times. Having no federal financial assistance in purchasing reserve anti-TB drugs and consumables for microbiological tests, it is impossible to diagnose multidrug resistance and to cure patients with multidrug-resistant tuberculosis at the expense of the budgets of the Russian Federation’s subjects.
topic tuberculosis
tuberculosis institutions
public health financing
multidrug resistance
hiv infection
russia’s state public health development program
targets
indicators
url https://www.tibl-journal.com/jour/article/view/312
work_keys_str_mv AT obnechaeva thetargetsandindicatorsofrussiasstatepublichealthprogramupto2020
AT sasterlikov thetargetsandindicatorsofrussiasstatepublichealthprogramupto2020
AT nbkhurieva thetargetsandindicatorsofrussiasstatepublichealthprogramupto2020
AT obnechaeva targetsandindicatorsofrussiasstatepublichealthprogramupto2020
AT sasterlikov targetsandindicatorsofrussiasstatepublichealthprogramupto2020
AT nbkhurieva targetsandindicatorsofrussiasstatepublichealthprogramupto2020
_version_ 1721264315890139136